[1]刘梦荻,董锦,姜中华.血清CRLF1、PRDX6联合检测对早期胃癌内镜黏膜下剥离术后复发的预测价值[J].陕西医学杂志,2025,54(9):1233-1236,1290.[doi:DOI:10.3969/j.issn.1000-7377.2025.09.014]
　LIU Mengdi,DONG Jin,JIANG Zhonghua.Predictive value of combined detection of serum CRLF1 and PRDX6 for recurrence of early gastric cancer after endoscopic submucosal dissection[J].,2025,54(9):1233-1236,1290.[doi:DOI:10.3969/j.issn.1000-7377.2025.09.014]
点击复制

血清CRLF1、PRDX6联合检测对早期胃癌内镜黏膜下剥离术后复发的预测价值

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年9期
页码:
1233-1236,1290
栏目:
临床研究
出版日期:
2025-09-05

文章信息/Info

Title:
Predictive value of combined detection of serum CRLF1 and PRDX6 for recurrence of early gastric cancer after endoscopic submucosal dissection
作者:
刘梦荻; 董锦; 姜中华
（盐城市第一人民医院消化内科，江苏 盐城 224000）
Author(s):
LIU Mengdi; DONG Jin; JIANG Zhonghua
(Department of Gastroenterology,Yancheng No.1 People’s Hospital,Yancheng 224000,China)
关键词:
早期胃癌; 细胞因子受体样因子1; 过氧化物还原蛋白6; 内镜黏膜下剥离术; 复发; 预测价值
Keywords:
Early gastric cancer; Cytokine receptor like factor 1; Peroxiredoxin 6; Endoscopic submucosal dissection; Recurrence; Predictive value
分类号:
R 735.2
DOI:
DOI:10.3969/j.issn.1000-7377.2025.09.014
文献标志码:
A
摘要:
目的：探讨血清细胞因子受体样因子1（CRLF1）、过氧化物还原蛋白6（PRDX6）对早期胃癌内镜黏膜下剥离术（ESD）后复发的预测价值。方法：选取早期胃癌患者82例（均行ESD治疗）为研究组，选取同期病理检查确诊的良性病变患者82例为对照组。采用实时荧光定量PCR检测CRLF1、PRDX6 mRNA水平，分析两者相关性、ESD术后复发影响因素及对ESD术后复发的预测价值。结果：与对照组比较，研究组血清CRLF1 mRNA降低，PRDX6 mRNA水平升高（均P<0.05）。血清CRLF1 mRNA与PRDX6 mRNA呈负相关（r=－0.596，P＜0.05）。经1年随访，82例患者中，16例复发。复发组黏膜下浸润占比高于未复发组（P<0.05）。复发组血清CRLF1 mRNA水平显著低于未复发组，血清PRDX6 mRNA水平显著高于未复发组（均P<0.05）。浸润深度、PRDX6 mRNA为危险因素，CRLF1 mRNA为保护因素（均P＜0.05）。血清CRLF1 mRNA、PRDX6 mRNA对早期胃癌ESD术后复发均有良好的预测价值，两项联合预测优于单项预测（均P＜0.05）。结论：早期胃癌患者血清CRLF1水平明显降低，PRDX6水平明显升高，两项联合检测对胃癌ESD术后复发有良好的预测价值。
Abstract:
Objective:To investigate the predictive value of serum cytokine receptor-like factor 1 (CRLF1) and peroxiredoxin 6 (PRDX6) for recurrence after endoscopic submucosal dissection (ESD) in early gastric cancer.Methods：Eighty-two cases of early gastric cancer patients (all of whom were treated with ESD) were selected as study group,and another 82 cases of benign lesions diagnosed by pathological examination during the same period were selected as control group.Real-time fluorescence quantitative PCR was used to detect the levels of CRLF1 and PRDX6 mRNA,and to analyze the correlation between them,the factors influencing the recurrence after ESD and the predictive value for the recurrence after ESD.Results:Compared with the control group,the serum CRLF1 mRNA level was decreased and PRDX6 mRNA level was increased in the study group (both P<0.05).Serum CRLF1 was negatively correlated with PRDX6 mRNA (r=－0.596,P<0.05).After 1 year of follow-up,16 of the 82 patients had recurrence.The proportion of submucosal infiltration in the recurrence group was higher than that in the non-recurrence group (P<0.05).The serum CRLF1 mRNA level in the recurrence group was obviously lower than that in the non-recurrence group,and the serum PRDX6 mRNA level was prominently higher than that in the non-recurrence group (all P<0.05).Infiltration depth and PRDX6 mRNA were risk factors,and CRLF1 mRNA was a protective factor (all P<0.05).Serum CRLF1 mRNA and PRDX6 mRNA had good predictive value for recurrence after ESD for early gastric cancer,and the combination of the two was better than single prediction (both P<0.05).Conclusion:Serum CRLF1 level is significantly decreased and PRDX6 level is significantly increased in patients with early gastric cancer.The combined detection of the two indexes has a good predictive value for the recurrence of gastric cancer after ESD.

参考文献/References:

[1]李发旺,尹雯,王兴胜,等.胃镜下联合染色观察方法对癌前病变及早期胃癌检出率的影响[J].中国内镜杂志,2021,27(1):76-80.
[2]ESAKI M,IHARA E,SUMIDA Y,et al.Hybrid and conventional endoscopic submucosal dissection for early gastric neoplasms:A multi-center randomized controlled trial[J].Clin Gastroenterol Hepatol,2023,21(7):1810-1818.e8.
[3]LIU Q,DING L,QIU X,et al.Updated evaluation of endoscopic submucosal dissection versus surgery for early gastric cancer:A systematic review and meta-analysis[J].Int J Surg,2020,73(1):28-41.
[4]武云飞,孟岩,张卫彬,等.miR-182表达与早期胃癌患者内镜黏膜下剥离术后复发的关系[J].山东医药,2021,61(19):13-16.
[5]CRISPONI L,BUERS I,RUTSCH F.CRLF1 and CLCF1 in development,health and disease[J].Int J Mol Sci,2022,23(2):992-997.
[6]LI Y,XUN J,WANG B,et al.MiR-3065-3p promotes stemness and metastasis by targeting CRLF1 in colorectal cancer[J].J Transl Med,2021,19(1):429-435.
[7]刘谦,袁晟,刘勇.弥漫大B细胞淋巴瘤中Prdx6的表达及其预后意义[J].临床与实验病理学杂志,2021,37(3):279-283.
[8]CHEN Z,LIN J,WANG H,et al.Expression and clinical role of PRDX6 in lung adenocarcinoma[J].J Int Med Res,2024,52(3):3000605241236276.
[9]中华医学会消化内镜学分会,中国抗癌协会肿瘤内镜专业委员会.中国早期胃癌筛查及内镜诊治共识意见(2014年,长沙)[J].中华消化杂志,2014,34(7):433-448.
[10]北京市科委重大项目《早期胃癌治疗规范研究》专家组,柴宁莉,翟亚奇,等.早期胃癌内镜下规范化切除的专家共识意见(2018,北京)[J].中华胃肠内镜电子杂志,2018,5(2):49-60.
[11]韩艳平,菅广敏,边菁,等.早期胃癌患者血清TK1、STAT1、sB7-H4水平变化及对内镜黏膜下剥离术预后的预测价值[J].河南医学研究,2024,33(11):1986-1990.
[12]于航,杨爱明,陆星华,等.尿路上皮癌抗原1在早期胃癌中的表达及其对胃癌细胞增殖和迁移的作用机制[J].中华消化杂志,2020,40(9):627-630.
[13]熊欢,蒋丹丹,陈涛,等.窄带成像技术联合放大内镜在胃上皮内瘤变及早期胃癌中的应用价值[J].陕西医学杂志,2024,53(11):1517-1520.
[14]王博达,张垚,付依凡,等.甲胎蛋白阳性胃癌和胃肝样腺癌预后危险因素对比分析[J].空军军医大学学报,2024,45(3):270-276.
[15]但汉君,郑高赞,田野,等.老年胃癌根治性切除手术患者预后影响因素分析[J].空军军医大学学报,2024,45(3):277-281.
[16]LEE H,LEE H H,SONG K Y,et al.Negative impact of endoscopic submucosal dissection on short-term surgical outcomes of subsequent laparoscopic distal gastrectomy for gastric cancer[J].Ann Surg Oncol,2020,27(1):313-320.
[17]何金品,石拓,陈星星.益胃生津行气汤联合内镜下黏膜剥离术治疗早期胃癌临床研究[J].陕西中医,2024,45(8):1061-1064.
[18]肖蓓.ESD治疗早期胃癌的效果及术后复发相关因素研究[J].国际医药卫生导报,2020,26(10):1407-1409.
[19]孙骥,熊永福,崔文娟,等.分泌蛋白CRLF1表达对结直肠癌细胞增殖和细胞克隆能力的影响[J].现代医学,2021,49(9):995-1001.
[20]邓桢,雷钊,朱红伟,等.SOCS1调控JAK/STAT通路传导抑制肝癌细胞增殖、侵袭、迁移的机制研究[J].中国现代手术学杂志,2021,25(1):8-14.
[21]CHEN J,ALI M W,YAN L,et al.Prioritization and functional analysis of GWAS risk loci for Barrett’s esophagus and esophageal adenocarcinoma[J].Hum Mol Genet,2022,31(3):410-422.
[22]高超,谢博.血清miR-3065-3p、CRLF1与结肠癌病理特征的关系及对术后肝转移风险的评估价值分析[J].国际检验医学杂志,2023,44(7):841-847.
[23]LPEZ-GRUESO M J,LAGAL D J,GARCA-JIMNEZ  F,et al.Knockout of PRDX6 induces mitochondrial dysfunction and cell cycle arrest at G2/M in HepG2 hepatocarcinoma cells[J].Redox Biol,2020,37(1):101737-101743.
[24]徐鑫鑫,吴传楠,庄斐,等.食管鳞癌患者血清PRDX6、白介素-2及白介素-6差异表达的临床应用价值[J].现代消化及介入诊疗,2023,28(1):67-73.
[25]母润红,刘馨竹,林睿,等.PRDX6过表达对肝癌细胞增殖、侵袭和迁移的影响及其分子机制[J].吉林大学学报(医学版),2021,47(3):559-565.
[26]马淑萍,蒙玉娜,党春艳,等.锰超氧化物歧化酶和过氧化物酶6在弥漫性大B细胞淋巴瘤中的表达及临床意义[J].陕西医学杂志,2021,50(9):1154-1157.
[27]李犹龙,张飞功,严桦,等.术前血清中NPM1和PRDX6的表达对结肠癌根治术后预后的评估价值[J].标记免疫分析与临床,2024,31(4):616-621.

相似文献/References:

[1]熊 欢,蒋丹丹,陈 涛,等.窄带成像技术联合放大内镜在胃上皮内瘤变及早期胃癌中的应用价值[J].陕西医学杂志,2024,(11):1517.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.017]
　XIONG Huan,JIANG Dandan,CHEN Tao,et al.Application value of narrow band imaging combined with magnifying endoscopy in gastric intraepithelial neoplasia and early gastric cancer[J].,2024,(9):1517.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.017]
[2]王卫卫,邢文韬,张爱青,等.血管内皮生长因子、程序性死亡受体-1联合胃功能三项对早期胃癌的诊断及预后评估价值[J].陕西医学杂志,2024,(12):1663.[doi:DOI:10.3969/j.issn.1000-7377.2024.12.015]
　WANG Weiwei,XING Wentao,ZHANG Aiqing,et al.Value of VEGF,PD-1 combined with gastric function in diagnosis and prognosis evaluation of early gastric cancer[J].,2024,(9):1663.[doi:DOI:10.3969/j.issn.1000-7377.2024.12.015]

备注/Memo

备注/Memo:
江苏省基础研究计划（自然科学基金）专项资金资助项目（BK20210265）
更新日期/Last Update: 2025-09-04